Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 1,634 shares at $135.28 ($221K) on 2016-10-31, disclosed to the SEC on 2016-11-02.
Seasonal sale ($221k) by Director — this insider has traded ALXN in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.28 | 1,300 | $176K | 79.5% |
| 2 | $135.37 | 334 | $45K | 20.5% |
| Total | $135.30 avg | 1,634 | $221K | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |